搜索
 >  生物标记素蛋白>Cetuximab >Biotinylated Anti-Cetuximab Antibodies (recommended for PK/PD)

Biotinylated Anti-Cetuximab Antibodies (recommended for PK/PD)

表达区间及表达系统(Source)

Mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Cetuximab F(ab')2.

亚型(Isotype)

IgG1/kappa

特异性(Specificity)

Recognizes Cetuximab specifically, no cross reactivity with other humanized antibodies.

标记(Biotinylation)

The primary amines in the side chains of lysine residues and the N-terminus of the protein are conjugated with biotins using standard chemical labeling method. A specially optimized long-spacer biotin reagent (13.5 angstroms) is used in this product to minimize potential steric hindrance.

蛋白标记度(Biotin:Protein Ratio)

The biotin to protein ratio is 1-3 as determined by the HABA assay.

纯度(Purity)

>90% as determined by SDS-PAGE.

制剂(Formulation)

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization.

重构方法(Reconstitution)

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储(Storage)

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

No activity loss was observed after storage at:

  1. 4-8°C for 12 months in lyophilized state;
  2. -70°C for 3 years under sterile conditions after reconstitution.
 

电泳(SDS-PAGE)

Biotinylated Anti-Cetuximab Antibodies (recommended for PK/PD) (Cat. No. CEB-BY31) SDS-PAGE gel

Biotinylated Anti-Cetuximab Antibodies (recommended for PK/PD) on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.

 

活性(Bioactivity)-ELISA

Biotinylated Human ELISA

Detection of cetuximab by bridging ELISA in serum. Immobilized Anti-Cetuximab Antibodies (Cat. No. CEB-Y29) at 2 μg/ml, added increasing concentrations of cetuximab (10% human serum) and then added Biotinylated Anti-Cetuximab Antibodies (Cat. No. CEB-BY31) at 1 μg/ml. Detection was performed using HRP-conjugated streptavidin with a sensitivity of 6 ng/ml.

点击申请Protocol

Biotinylated Human SPR

Immobilized cetuximab at 0.1 μg/mL (100 μL/well) can bind Biotinylated Anti-Cetuximab Antibodies (Cat. No. CEB-BY31) with a linear range of 0.39-25 ng/mL.

点击申请Protocol

Biotinylated Human ELISA

ELISA analysis shows that the binding of cetuximab to Human EGF R, His Tag (Cat. No. EGR-H5222) was inhibited by increasing concentration of Biotinylated Anti-Cetuximab Antibodies (Cat. No. CEB-BY31). The concentration of cetuximab used is 3 ng/ml.

点击申请Protocol

背景(Background)

Cetuximab is an epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable; antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions.

 

前沿进展

货号/价格

CEB-BY31-25ug / ¥3500

CEB-BY31-200ug / ¥13800

开发建议
文档
联系电话:
400-682-2521(全国)
010-57737274(北京)
021-26136428(上海)
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
techsupport@acrobiosystems.com

消息提示

请输入您的联系方式,再点击提交!

确定